Milligan, Graeme.
Graeme Milligan researcher
Milligan, Graeme, 19..-....
Milligan, G.
VIAF ID: 93081103 (Personal)
Permalink: http://viaf.org/viaf/93081103
Preferred Forms
- 100 0 _ ‡a Graeme Milligan ‡c researcher
- 200 _ | ‡a Milligan ‡b Graeme
- 100 1 _ ‡a Milligan, G.
- 100 1 _ ‡a Milligan, Graeme
-
-
- 100 1 _ ‡a Milligan, Graeme
-
-
-
-
-
-
- 100 1 _ ‡a Milligan, Graeme
- 100 1 _ ‡a Milligan, Graeme, ‡d 19..-....
-
4xx's: Alternate Name Forms (7)
5xx's: Related Names (1)
Works
Title | Sources |
---|---|
Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases | |
Allostery at G protein-coupled receptor homo- and heteromers: uncharted pharmacological landscapes | |
The antiallergic mast cell stabilizers lodoxamide and bufrolin as the first high and equipotent agonists of human and rat GPR35 | |
beta-Arrestin 1 and Galphaq/11 coordinately activate RhoA and stress fiber formation following receptor stimulation | |
Beta-arrestin 2-dependent angiotensin II type 1A receptor-mediated pathway of chemotaxis | |
Building a new conceptual framework for receptor heteromers | |
Chemokine receptor CXCR4 oligomerization is disrupted selectively by the antagonist ligand IT1t | |
Combinatorial expression of GPCR isoforms affects signalling and drug responses | |
Dietary fibers inhibit obesity in mice, but host responses in the cecum and liver appear unrelated to fiber-specific changes in cecal bacterial taxonomic composition | |
Discovery of a potent and selective GPR120 agonist. | |
Dynamic Regulation of Quaternary Organization of the M1 Muscarinic Receptor by Subtype-selective Antagonist Drugs. | |
Evidence for the Existence of a CXCL17 Receptor Distinct from GPR35. | |
Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance | |
FFA4/GPR120: Pharmacology and Therapeutic Opportunities. | |
The First 50 Years of Molecular Pharmacology | |
Free Fatty Acid Receptors | |
G protein-coupled receptors : structure, signaling, and physiology | |
G-proteins and signal transduction : Biochemical society symposium no 56 held at St Bartholomew's Hospital medical college, London, December 1989 | |
G-proteins as mediators of cellular signalling processes, 1990: | |
A general method to quantify ligand-driven oligomerization from fluorescence-based images | |
High-content assays for ligand regulation of G-protein-coupled receptors | |
Identification of novel species-selective agonists of the G-protein-coupled receptor GPR35 that promote recruitment of β-arrestin-2 and activate Gα13. | |
Indomethacin treatment prevents high fat diet-induced obesity and insulin resistance but not glucose intolerance in C57BL/6J mice | |
The M<sub>1</sub> muscarinic receptor is present in situ as a ligand-regulated mixture of monomers and oligomeric complexes | |
Mechanism and function of Drosophila capa GPCR: a desiccation stress-responsive receptor with functional homology to human neuromedinU receptor | |
Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation | |
On-target and off-target effects of novel orthosteric and allosteric activators of GPR84 | |
Palmitoylation regulates regulators of G-protein signaling (RGS) 16 function. I. Mutation of amino-terminal cysteine residues on RGS16 prevents its targeting to lipid rafts and palmitoylation of an internal cysteine residue | |
Presynaptic control of striatal glutamatergic neurotransmission by adenosine A1-A2A receptor heteromers | |
Selective interactions between helix VIII of the human mu-opioid receptors and the C terminus of periplakin disrupt G protein activation | |
Signal transduction : a practical approach | |
A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptor | |
Src-mediated RGS16 tyrosine phosphorylation promotes RGS16 stability | |
The therapeutic potential of allosteric ligands for free fatty acid sensitive GPCRs. | |
Therapeutic validation of an orphan G protein-coupled receptor: The case of GPR84 | |
Uncovering the pharmacology of the G protein-coupled receptor GPR40: high apparent constitutive activity in guanosine 5'-O-(3-[35S]thio)triphosphate binding studies reflects binding of an endogenous agonist | |
Up-regulation of the angiotensin II type 1 receptor by the MAS proto-oncogene is due to constitutive activation of Gq/G11 by MAS |